DISCLOSEDQuarterly
Viking Global Investors
Damora Therapeutics Inc · NASDAQ
2,311,082 sh · $60.1M
Filed 30 Jun 2026SEC 13Fview source
Viking Global Investors
Damora Therapeutics Inc · NASDAQ
2,311,082 sh · $60.1M
Viking Global Investors
Damora Therapeutics Inc · NASDAQ
2,311,082 sh · $59.9M